Lung Cancer Trial, Recruiting (NCT06360822)

Lung Cancer Trial, Recruiting NCT06360822 Sponsor: Indiana University Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06360822 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 50 and 80 years old, have smoked at some point in the last 15 years, and have a smoking history of at least 20 pack-years (this means, for example, smoking one pack a day for 20 years, or two packs a day for 10 years)

Who may not be able to join:

You do not speak English or Spanish
You are currently experiencing a severe psychiatric crisis, such as thoughts of harming yourself or others, or are experiencing psychosis (confirm with trial site)
You are currently under the influence of alcohol or drugs
You are unable to provide a reliable way to be contacted for follow-up, such as a cell phone number
You are visiting the emergency department for a life-threatening condition
You have had a chest CT scan within the past 12 months
You are already enrolled in a lung cancer screening program
You are currently enrolled in hospice care

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06360822

Sponsor: Indiana University

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT06360822

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 50 and 80 years old, have smoked at some point in the last 15 years, and have a smoking history of at least 20 pack-years (this means, for example, smoking one pack a day for 20 years, or two packs a day for 10 years)

Who may not be able to join:

You do not speak English or Spanish
You are currently experiencing a severe psychiatric crisis, such as thoughts of harming yourself or others, or are experiencing psychosis (confirm with trial site)
You are currently under the influence of alcohol or drugs
You are unable to provide a reliable way to be contacted for follow-up, such as a cell phone number
You are visiting the emergency department for a life-threatening condition
You have had a chest CT scan within the past 12 months
You are already enrolled in a lung cancer screening program
You are currently enrolled in hospice care

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Indiana University

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

1 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of patients receive Lung Cancer Screening

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov